STUDY OF A TREND IN THE FREQUENCY OF USING MAIN DRUG CLASSES INDICATED FOR THE TREATMENT OF PATIENTS WITH CHRONIC CORONARY HEART DISEASE IN 2004 TO 2014: DATA FROM THE CHD PROGNOSIS REGISTRY
Objective: to estimate a trend in the frequency of using drugs with their proven effect on disease outcome in patients with chronic coronary heart disease (CHD) in 2004–2014 within the CHD PROGNOSIS registry. Materials and methods. The investigation included data from the CHD PROGNOSIS registry on 3...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2016-06-01
|
| Series: | Klinicist |
| Subjects: | |
| Online Access: | https://klinitsist.abvpress.ru/Klin/article/view/243 |
| _version_ | 1797855585679441920 |
|---|---|
| author | S. N. Tolpygina S. Yu. Martsevich |
| author_facet | S. N. Tolpygina S. Yu. Martsevich |
| author_sort | S. N. Tolpygina |
| collection | DOAJ |
| description | Objective: to estimate a trend in the frequency of using drugs with their proven effect on disease outcome in patients with chronic coronary heart disease (CHD) in 2004–2014 within the CHD PROGNOSIS registry. Materials and methods. The investigation included data from the CHD PROGNOSIS registry on 303 patients with verified CHD during the 2004–2007 reference hospitalization at the National Research Center for Preventive Medicine, who made a control visit 4 years later, and those on 125 patients who had come following 7 years. Results. There was a low frequency of prescribing the drugs that were able to improve prognosis in patients with stable CHD prior to the 2004–2007 reference hospitalization with an increase at discharge and with a further reduction during outpatient treatment. 7.6 and 86.5% of the patients took statins; 68 and 96 % received disaggregants; 24.8 and 94 % used β-adrenoblockers (β-AB), and 19 and 83 % had angiotensin-converting enzyme (ACE) inhibitors before hospitalization and at discharge, respectively (p < 0.001). Four and seven years after discharge, there were reductions in the frequency of using statins to 67 and 70 %, disaggregants to 80 and 90 %, β-AB to 80 and 75 %, and ACE inhibitors to 66 and 65 %, respectively (p < 0.01). At the same time, the above-mentioned drugs were taken by 15 and 69 % of patients on admission and at discharge, respectively (p < 0.001), by 41 and 35 % after 4 and 7 years (p < 0.01). In 2004 to 2014, most drugs were used at low and moderate doses with a gradual increase in the share of generics. Conclusion. The therapy in patients with stable CHD was characterized by a low frequency of using the drugs with their proven effect on prognosis prior to the 2004–2007 reference hospitalization with an increase and a decrease in the frequency of their use on discharge and after 4 and 7 years. During 10 years, β-AB, ACE inhibitors/angiotensin II receptor antagonists, and statins were used mainly at low and moderate doses. Moreover, there was a gradual rise in the share of generics, in the use of statins in particular. |
| first_indexed | 2024-04-09T20:26:14Z |
| format | Article |
| id | doaj.art-10efd74ddfd14689ad25a3aace710c24 |
| institution | Directory Open Access Journal |
| issn | 1818-8338 |
| language | Russian |
| last_indexed | 2024-04-09T20:26:14Z |
| publishDate | 2016-06-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Klinicist |
| spelling | doaj.art-10efd74ddfd14689ad25a3aace710c242023-03-30T20:14:09ZrusABV-pressKlinicist1818-83382016-06-01101293510.17650/1818-8338-2016-10-1-29-35233STUDY OF A TREND IN THE FREQUENCY OF USING MAIN DRUG CLASSES INDICATED FOR THE TREATMENT OF PATIENTS WITH CHRONIC CORONARY HEART DISEASE IN 2004 TO 2014: DATA FROM THE CHD PROGNOSIS REGISTRYS. N. Tolpygina0S. Yu. Martsevich1National Research Center for Preventive Medicine, Ministry of Health of Russia; Build. 3, 10 Petroverigskiy Pereulok, Moscow, 101990, RussiaNational Research Center for Preventive Medicine, Ministry of Health of Russia; Build. 3, 10 Petroverigskiy Pereulok, Moscow, 101990, RussiaObjective: to estimate a trend in the frequency of using drugs with their proven effect on disease outcome in patients with chronic coronary heart disease (CHD) in 2004–2014 within the CHD PROGNOSIS registry. Materials and methods. The investigation included data from the CHD PROGNOSIS registry on 303 patients with verified CHD during the 2004–2007 reference hospitalization at the National Research Center for Preventive Medicine, who made a control visit 4 years later, and those on 125 patients who had come following 7 years. Results. There was a low frequency of prescribing the drugs that were able to improve prognosis in patients with stable CHD prior to the 2004–2007 reference hospitalization with an increase at discharge and with a further reduction during outpatient treatment. 7.6 and 86.5% of the patients took statins; 68 and 96 % received disaggregants; 24.8 and 94 % used β-adrenoblockers (β-AB), and 19 and 83 % had angiotensin-converting enzyme (ACE) inhibitors before hospitalization and at discharge, respectively (p < 0.001). Four and seven years after discharge, there were reductions in the frequency of using statins to 67 and 70 %, disaggregants to 80 and 90 %, β-AB to 80 and 75 %, and ACE inhibitors to 66 and 65 %, respectively (p < 0.01). At the same time, the above-mentioned drugs were taken by 15 and 69 % of patients on admission and at discharge, respectively (p < 0.001), by 41 and 35 % after 4 and 7 years (p < 0.01). In 2004 to 2014, most drugs were used at low and moderate doses with a gradual increase in the share of generics. Conclusion. The therapy in patients with stable CHD was characterized by a low frequency of using the drugs with their proven effect on prognosis prior to the 2004–2007 reference hospitalization with an increase and a decrease in the frequency of their use on discharge and after 4 and 7 years. During 10 years, β-AB, ACE inhibitors/angiotensin II receptor antagonists, and statins were used mainly at low and moderate doses. Moreover, there was a gradual rise in the share of generics, in the use of statins in particular.https://klinitsist.abvpress.ru/Klin/article/view/243chronic coronary heart diseaseregistrydrug therapyuse frequencydosesbrand-name drugsgenericsclinical recommendationsstatinsbeta-adrenoblockersantiaggregantschronic heart failure |
| spellingShingle | S. N. Tolpygina S. Yu. Martsevich STUDY OF A TREND IN THE FREQUENCY OF USING MAIN DRUG CLASSES INDICATED FOR THE TREATMENT OF PATIENTS WITH CHRONIC CORONARY HEART DISEASE IN 2004 TO 2014: DATA FROM THE CHD PROGNOSIS REGISTRY Klinicist chronic coronary heart disease registry drug therapy use frequency doses brand-name drugs generics clinical recommendations statins beta-adrenoblockers antiaggregants chronic heart failure |
| title | STUDY OF A TREND IN THE FREQUENCY OF USING MAIN DRUG CLASSES INDICATED FOR THE TREATMENT OF PATIENTS WITH CHRONIC CORONARY HEART DISEASE IN 2004 TO 2014: DATA FROM THE CHD PROGNOSIS REGISTRY |
| title_full | STUDY OF A TREND IN THE FREQUENCY OF USING MAIN DRUG CLASSES INDICATED FOR THE TREATMENT OF PATIENTS WITH CHRONIC CORONARY HEART DISEASE IN 2004 TO 2014: DATA FROM THE CHD PROGNOSIS REGISTRY |
| title_fullStr | STUDY OF A TREND IN THE FREQUENCY OF USING MAIN DRUG CLASSES INDICATED FOR THE TREATMENT OF PATIENTS WITH CHRONIC CORONARY HEART DISEASE IN 2004 TO 2014: DATA FROM THE CHD PROGNOSIS REGISTRY |
| title_full_unstemmed | STUDY OF A TREND IN THE FREQUENCY OF USING MAIN DRUG CLASSES INDICATED FOR THE TREATMENT OF PATIENTS WITH CHRONIC CORONARY HEART DISEASE IN 2004 TO 2014: DATA FROM THE CHD PROGNOSIS REGISTRY |
| title_short | STUDY OF A TREND IN THE FREQUENCY OF USING MAIN DRUG CLASSES INDICATED FOR THE TREATMENT OF PATIENTS WITH CHRONIC CORONARY HEART DISEASE IN 2004 TO 2014: DATA FROM THE CHD PROGNOSIS REGISTRY |
| title_sort | study of a trend in the frequency of using main drug classes indicated for the treatment of patients with chronic coronary heart disease in 2004 to 2014 data from the chd prognosis registry |
| topic | chronic coronary heart disease registry drug therapy use frequency doses brand-name drugs generics clinical recommendations statins beta-adrenoblockers antiaggregants chronic heart failure |
| url | https://klinitsist.abvpress.ru/Klin/article/view/243 |
| work_keys_str_mv | AT sntolpygina studyofatrendinthefrequencyofusingmaindrugclassesindicatedforthetreatmentofpatientswithchroniccoronaryheartdiseasein2004to2014datafromthechdprognosisregistry AT syumartsevich studyofatrendinthefrequencyofusingmaindrugclassesindicatedforthetreatmentofpatientswithchroniccoronaryheartdiseasein2004to2014datafromthechdprognosisregistry |